Why the Dow is having a killer month as it heads for best October ever
The Dow Jones Industrial Average has been criticized by some market watchers for being a…
Read MoreThe Dow Jones Industrial Average has been criticized by some market watchers for being a…
Read MoreThe Dow Jones Industrial Average has been criticized by some market watchers for being a…
Read More
Get ready for more merger mania in pharma sector the rest of the year
Pfizer Inc.’s PFE, +0.45% $5.4 billion acquisition of Global Blood Therapeutics Inc. GBT, -0.02% is…
Read More